Ingestible Sensors Market Size, Share, Opportunities, And Trends By Sensor Type (Temperature, Image, PH, Pressure), By End-User Industry (Healthcare, Sports & Fitness), And By Geography - Forecasts From 2024 To 2029

The ingestible sensors market is expected to grow at a CAGR of 9.10%, reaching a market size of US$1,092.077 million in 2029 from US$706.603 million in 2024.

Ingestible electronic systems comprise a biocompatible microprocessor, power supply, sensors, and other components, enabling the device to communicate with a mobile application for diagnosis and monitoring. These capsule-sized devices possess the potential to screen for diseases that are difficult, if not impossible, to detect at an early stage using other methods. Furthermore, they can also reduce the facility and labour expenses typically associated with multiple procedures and offer a foundation for epithelial-targeted therapeutic interferences. These technological advancements can make disease monitoring and treatment for various conditions far more effective, enabling patients to live longer and healthier. Increased chronic diseases and advancing technologies will promote market growth in the forecasted period.

Furthermore, ongoing scientific and technological advancements that have resulted in the creation and development of tiny camera pills that are widely used in ingestible sensors as well as the introduction of cutting-edge sensor technologies by major players are significantly expanding the market's growth prospects. For example, in December 2022, engineers announced that they had created an ingestible biosensing system that is pill-shaped, battery-free, and provides real-time, continuous monitoring of the intestinal environment.

Ingestible Sensors Market Drivers:

• Increasing demand from the healthcare industry

For nearly two decades, capsule endoscopes have been on the market. Hence, the medical and healthcare sector had the highest market size in 2018. In the medical field, ingestible sensors are used in controlled drug delivery, patient monitoring, and capsule endoscopy. This helps patients maintain their medication regimes by informing doctors about drug interactions and specific drugs used by patients. These additional advantages have also led to an increase in their demand in this medical vertical. When it comes to endoscopic imaging, capsule endoscopy is accurate and effective.

Consequently, developed markets provide reimbursements for capsule endoscopy procedures. The rise of gastrointestinal disorders is expected to be another factor driving the growth of capsule endoscopy, thus pushing that market up.

• The increasing prevalence of chronic health conditions due to growing sedentary lifestyles

Sedentary lifestyles caused by a lack of physical activity, changing dietary habits, and increasing desk work are contributing to rising associated health risks. According to the World Health Organization's Global Action Plan of Physical Activity 2018-2030, approximately one out of every four adults and three out of every four youngsters fail to meet the organization's physical activity standards. Additionally, issues like better economic growth and moving to towns from villages, therefore creating the urban life seen today, modern transport systems have resulted in inactivity rates reaching 70% in certain countries.

• Increasing technological advancements

Due to technological advancements in electronic components, it is easier for people to create smarter, smaller, efficient, and multifunctional devices. This means that such a capsule embeds a noninvasive sensor that not only measures blood pressure and glucose levels but also tracks medication doses, takes pictures, and observes patients' intestinal microflora. The captured data is sent to the smartphone application or digital portals, enabling physicians and patients to record and monitor the data. The broad penetration of smartphones has further augmented the utility of this application.

Ingestible Sensors Market Restraint:

• Expensive and time-consuming regulatory approvals.

Laws and regulations surrounding ingestible sensors are lagging behind science and technology, creating obstacles to their market growth. As a result, their demand is growing, but there is a delay in entering the market because of the lengthy protocols involved in their approval. Despite this high need for these swallowable products among patients, poor legislative frameworks have continued to limit their acceptance. On the other hand, data collection and transmission using ingested sensors raises issues of both data protection and privacy. The approval of PillCam COLON 2 took longer than expected, thereby hindering Medtronic's attempts to make it available in the market, whereby its patients do not get access to this technology at all.

Startups in business and smaller organizations may also find it hard to gain their licenses since they need additional capital to easily run through such processes within different laws and regulations.

Ingestible Sensors Market Geographical Outlook

• North America is expected to hold a significant market share in the forecast period.

The North American region is expected to hold a large market share for this sector. Furthermore, concerning technological advancements and the increasing application of the Internet of Things (IoT) in healthcare, the United States leads the pack. IOT essentially allows for online tracking, monitoring, and control of people’s daily activities, such as taking medication. It is a new wave of digital medication in the healthcare industry. Scientific and technological advancements that led to the creation of tiny camera pills—widely utilized in these products—will probably accelerate the region's growth. Its growth is also allegedly being fueled in large part by an increase in gastrointestinal and chronic illnesses.

Ingestible Sensors Market Developments:

• In November 2023, the Massachusetts Institute of Technology introduced the Ingestible electronic device to identify patients' respiratory depression. Besides being able to monitor sleep apnea patient’s heart and breathing rates, the new sensor can also be utilized in identifying people who are prone to opioid overdose. The capsule, which comes in the shape of a multivitamin, uses an accelerometer to measure the patient’s heartbeat and respiration rate. Apart from identifying sleep apnea, the apparatus might also help identify opioid overdoses in susceptible individuals.
• In April 2022, AARDEX Group, announced a strategic alliance with etectRx, Inc. To track medication-taking behaviours, this new partnership combines the ID-CapTM System, etectRx's smart pill, and MEMS Adherence Software (MEMS AS) from AARDEX Group. When combined, they offer a comprehensive, unbiased, and accurate way to monitor and control medication adherence to solid form dosages. The AARDEX Group's MEMS Adherence Hardware ecosystem continues to expand with the addition of etectRx, Inc. as a new partner. The ID-Tag, a capsule with an embedded ingestible wireless sensor, is a feature of the FDA-approved ID-Cap System. The sensor sends a low-power digital message from the stomach when it is swallowed. The collected data may be sent to MEMS AS, a program that uses exclusive algorithms to help sponsors comprehend patient dosing patterns, as part of the AARDEX Group integration. Following that, healthcare teams can use this data to better target interventions, risk-stratify patients, and increase medication adherence.

Key Market Segmentation:

The ingestible sensors market is segmented and analyzed as below:

• By Sensor Type
  • Temperature
  • Image
  • pH
  • Pressure
• By End-User Industry
  • Healthcare
  • Sports & Fitness
• By Geography
  • North America
    • United States
    • Canada
    • Mexico
  • South America
    • Brazil
    • Argentina
    • Others
  • Europe
    • Germany
    • UK
    • France
    • Spain
    • Others
  • Middle East and Africa
    • Saudi Arabia
    • Israel
    • Others
  • Asia Pacific
    • China
    • Japan
    • India
    • Indonesia
    • South Korea
    • Others